The DOJ says Christopher Obaze sold the pills directly to drug traffickers and falsified records to hide the profits.

Novo Nordisk (NVO) announced a new $2.2 billion deal with San Francisco-based biotech Sapterna (SEPN) for obesity pills.

Modesto Man Arrested in Tuolumne County After Over 2-Pounds of Suspected Fentanyl Pills Reported Found in Jamestown ...

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic diseases.